Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms
NCT ID: NCT07033741
Last Updated: 2025-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2025-01-08
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions the study seeks to answer are:
* Which key factors influence EMDR outcomes in terms of mediators, moderators, and predictors of its effectiveness for depressive symptoms?
* Do lower levels of individual psychological functioning at baseline, including high co-occurrence of personality domains and pathogenic personal beliefs, predict the effects of EMDR in treating depressive symptoms?
* Are baseline psychological comorbidities (anxiety, dissociation, post-traumatic symptoms, emotional dysregulation, and sleep difficulties) and the quality of the therapeutic alliance related to the effectiveness of EMDR therapy for depressive symptoms? Participants will be both therapists and patients.
* Eligible therapists must be certified members of the EMDR Italian National Association to ensure adherence to established standards in the practice of EMDR therapy and consistency in therapeutic delivery. Therapists will identify patients from their routine clinical practice who meet the study inclusion criteria and facilitate their enrollment.
* Eligible patients must meet the following criteria:
1. Being 18 years of age or older.
2. being able to give informed consent.
3. presenting clinically significant symptoms in at least one of the following domains: anxiety, depression, dissociative, or post-traumatic stress symptoms.
Individuals presenting with severe neurological impairment or other severe psychiatric conditions were excluded.
Researchers will combine data from multiple N-of-1 trials (N-of-1 or single-subject clinical trials studies) using a Bayesian multilevel random-effects meta-analysis and meta-regression to generate robust estimates of treatment efficacy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Eye Movement Desensitization and Reprocessing (EMDR) Working Mechanism
NCT01209377
RCT Comparing EMDR and CBT for Treatment of Resistant Depression
NCT03972033
EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients
NCT02634372
Efficacy of EMDR in the Treatment of Depression and Comorbid Anxiety
NCT04976413
The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis
NCT01743664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EMDR Therapy Group
Participants receive Eye Movement Desensitization and Reprocessing (EMDR) therapy in accordance with standardized clinical protocol. The assessment of clinically significant symptoms will be conducted using validated screening tools and diagnostic measures aligned with the study 's objectives. The initial session (Timepoint 0a \[T0a\]) will consist of a thorough baseline evaluation, in which participants will fill out a set of baseline self-report questionnaires. A second baseline assessment (T0b) will take place after the completion of four therapy sessions, focusing on changes in emotional regulation, personal beliefs, attachment style, and the processing of traumatic memories. Both the patient and therapist will evaluate the therapeutic alliance at T0b, offering insights into the evolving dynamics of the therapeutic process. After baseline assessments (T0a and T0b), additional assessments will occur at six (T6), twelve (T12), with a maximum follow-up period of eighteen months (T18).
EMDR
The EMDR process follows an eight-phase protocol that includes (1) history taking: gathering patient's background information and planning treatment, (2) preparation: preparing the patient for processing target, (3) assessment: accessing target of the traumatic memories, (4) desensitization: processing target memories using dual task , (5) installation: strengthening the alternative positive cognition, (6) body scan: noting any physical sensations related to the target memory, (7) closure: ensuring patient's stability at the end of the session, and (8) revaluation: assessing effectiveness of the session and future planning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMDR
The EMDR process follows an eight-phase protocol that includes (1) history taking: gathering patient's background information and planning treatment, (2) preparation: preparing the patient for processing target, (3) assessment: accessing target of the traumatic memories, (4) desensitization: processing target memories using dual task , (5) installation: strengthening the alternative positive cognition, (6) body scan: noting any physical sensations related to the target memory, (7) closure: ensuring patient's stability at the end of the session, and (8) revaluation: assessing effectiveness of the session and future planning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 years or older
* capacity of providing informed consent
* presenting with clinically significant symptoms in at least one of the following domains: anxiety, depression, post-traumatic stress symptoms, or dissociative symptoms.
Exclusion Criteria
* history of psychotic symptoms or schizophrenia
* dementia
* severe personality disorders
* a serious, unstable medical condition
* acute suicidality that needs hospitalization.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Turin, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
luca ostacoli
Full Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Turin
Turin, Turin, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROCESS-EMDR/0565145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.